| 名稱 | UPCI-SCC-090（人舌頭鱗癌細胞） |
| 型號 | CBP60695 |
| 報價 |  |
| 特點 | UPCI-SCC-090（人舌頭鱗癌細胞） |
產品搜索
相關文章
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產品展示 / PRODUCTS
- 詳細內容
" _ue_custom_node_="true">
| CBP60695 | |
| I. General information | |
| Synonyms: | UPCI-SCC-090 |
| Background: | The surgically excised tumor was minced and distributed into flasks. When growth of fibroblasts obstructed the growth of the squamous cells, the fibroblasts were removed by trypsinization. The remaining squamous cells were grown and passaged. |
| Species: | Homo sapiens, human |
| Tissue: | Derived from metastatic site: tongue |
| Disease: | squamous cell carcinoma; grade 3; pathological stage: T2N0 |
| Gender: | Caucasian，male，46years |
| Morphology: | epithelial-like |
| Growth Mode: | adherent |
| DNA Profile: | Amelogenin: X,Y CSF1PO: 11,12 D5S818: 11, 12 D7S820: 9, 10 D13S317: 11 D16S539: 12,13 TH01: 7 TPOX: 8 vWA: 17 Cobioer’s Cell Line Authentication Service |
| Culture Medium: | MEM + 1% Non Essential Amino Acids (NEAA) + 1mM Sodium Pyruvate (NaP) + 10% FBS We strongly suggest to purchase the complete medium from Cobioer. |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | CK 19+; Keratin IHC AE1+; Keratin IHC AE3+; CAM 5.2+ |
| Oncogene: | amplification of chromosomal band 11q13, not expressed mutations of TP53 codon, not expressed |
| Comments: | UPCI:SCC090 is from a squamous cell carcinoma of the base of the tongue. These cells are positive for Human Papilloma Virus (HPV). They have no TP53 mutations as assayed by sequencing the 5-8 exons of TP53. UPCI:SCC090 showed no amplification of chromosomal band 11q13 using FISH. The patient had a recurrence about 1 year later sited at the hypopharynx. It is ATCC® No. CRL-3240 UPCI:SCC152™. These 2 HNSCC (head and neck squamous cell carcinoma) cell lines are a resource for studying the initiation, cancerization, prognosis, intervention and treatment of oral cancers. For more information, please contact Cobioer (4008-750-250). |
